Cathie Wood’s ARK Invest Buys Over 100,000 Shares of Disney
One of Cathie Wood's Ark Invest funds bought over 100,000 shares of Disney on July 26.
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 100,000 shares of Walt Disney Co. (NYSE: DIS | DIS Price Prediction) on Monday, as the price of this ETF was up less than 1% in Monday’s session. These funds are up a fair amount in the past year.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) added 102,929 shares of Disney. At Monday’s closing price, this would have valued this purchase at roughly $18.4 million. This is only a small fraction of the total holdings. ARKW is up 60% over the past 52 weeks.
Check out all of ARK Invest’s buys for Monday:
| Fund | Ticker | Company | Shares |
|---|---|---|---|
| ARKF | PATH | UiPath | 92,655 |
| ARKF | Z | Zillow | 160,633 |
| ARKF | TDOC | Teladoc Health | 250,353 |
| ARKF | STNE | StoneCo | 208,229 |
| ARKF | OPEN | Opendoor Technologies | 583,672 |
| ARKF | COIN | Coinbase Global | 113,043 |
| ARKF | FTCH | Farfetch | 242,823 |
| ARKG | VERV | Verve Therapeutics | 19,276 |
| ARKG | SGFY | Signify Health | 99,700 |
| ARKG | RPTX | Repare Therapeutics | 4,175 |
| ARKG | QSI | Quantum-Si | 506,400 |
| ARKG | PACB | Pacific Biosciences of California | 109,825 |
| ARKG | ACCD | Accolade | 81,704 |
| ARKG | IONS | Ionis Pharmaceutical | 182,409 |
| ARKK | PATH | UiPath | 32,456 |
| ARKK | U | Unity Software | 140,671 |
| ARKK | PACB | Pacific Biosciences of California | 255,299 |
| ARKK | FATE | Fate Therapeutics | 85,505 |
| ARKQ | TSP | TuSimple | 30,442 |
| ARKQ | BLDE | Blade Air Mobility | 116,400 |
| ARKQ | MGA | Magna International | 85,855 |
| ARKW | VUZI | Vuzix | 55,485 |
| ARKW | RBLX | Roblox | 180,341 |
| ARKW | KVSB | Khosla Venture Acquisition II | 71,276 |
| ARKW | DKNG | DraftKings | 137,480 |
| ARKW | DIS | Walt Disney | 102,929 |
| ARKX | LMT | Lockheed Martin | 4,044 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and non-voting shareholder of 24/7 Wall St.
[recirclink id=922611][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.
